Journal of Antimicrobial Chemotherapy (2000) 46, 15-22
© 2000 The British Society for Antimicrobial Chemotherapy
The ECO•SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens—interim report
Department of Clinical Microbiology, Central Hospital, S-351 85 Växjö, Sweden
The ECO•SENS Project is the first international survey to investigate the prevalence and susceptibility of pathogens causing community-acquired, uncomplicated urinary tract infections (UTIs) in women. At 240 centres in 17 countries, female patients presenting with symptoms of uncomplicated UTIs were asked to provide a urine sample for testing for the presence of leucocytes and bacteria. The bacteria were identified and their susceptibility to 12 antibiotics commonly used in the treatment of UTIs was determined. The objective of the survey was to collect 5000 urine samples to obtain approximately 3500 isolates of defined uropathogens. This interim report includes the results from 1960 urine samples, 75% of which contained a uropathogen. Escherichia coli accounted for the majority (80%) of uropathogens isolated in all 17 countries. The rates of resistance among E. coli strains were: ampicillin and sulphamethoxazole, 30%; trimethoprim alone or with sulphamethoxazole, 15%; nalidixic acid, 6%; ciprofloxacin, 3%; amoxycillin–clavulanic acid, mecillinam, cefadroxil, nitrofurantoin and fosfomycin, 2%. The use of ampicillin, sulphonamides and trimethoprim alone or with sulphamethoxazole needs to be reconsidered. The seemingly rapid increase in quinolone resistance among community-acquired E. coli in some of the countries gives cause for concern.
* Corresponding author. Tel: +46-470-58-74-77; Fax: +46-470-58-74-55; E-mail: gunnar.kahlmeter{at}ltkronoberg.se
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Castaneda-Garcia, A. Rodriguez-Rojas, J. R. Guelfo, and J. Blazquez The Glycerol-3-Phosphate Permease GlpT Is the Only Fosfomycin Transporter in Pseudomonas aeruginosa J. Bacteriol., November 15, 2009; 191(22): 6968 - 6974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sandegren, A. Lindqvist, G. Kahlmeter, and D. I. Andersson Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli J. Antimicrob. Chemother., September 1, 2008; 62(3): 495 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Uzunovic-Kamberovic Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina J. Antimicrob. Chemother., August 1, 2006; 58(2): 344 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ejrnaes, D. Sandvang, B. Lundgren, S. Ferry, S. Holm, T. Monsen, R. Lundholm, and N. Frimodt-Moller Pulsed-Field Gel Electrophoresis Typing of Escherichia coli Strains from Samples Collected before and after Pivmecillinam or Placebo Treatment of Uncomplicated Community-Acquired Urinary Tract Infection in Women. J. Clin. Microbiol., May 1, 2006; 44(5): 1776 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Blahna, C. A. Zalewski, J. Reuer, G. Kahlmeter, B. Foxman, and C. F. Marrs The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada J. Antimicrob. Chemother., April 1, 2006; 57(4): 666 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Johnson, B. Johnston, M. A. Kuskowski, R. Colodner, and R. Raz Spontaneous Conversion to Quinolone and Fluoroquinolone Resistance among Wild-Type Escherichia coli Isolates in Relation to Phylogenetic Background and Virulence Genotype Antimicrob. Agents Chemother., November 1, 2005; 49(11): 4739 - 4744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Dromigny, P. Nabeth, A. Juergens-Behr, and J. D. Perrier-Gros-Claude Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal J. Antimicrob. Chemother., July 1, 2005; 56(1): 236 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Landgren, H. Oden, I. Kuhn, A. Osterlund, and G. Kahlmeter Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries J. Antimicrob. Chemother., June 1, 2005; 55(6): 928 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Johnson, M. A. Kuskowski, T. T. O'Bryan, R. Colodner, and R. Raz Virulence Genotype and Phylogenetic Origin in Relation to Antibiotic Resistance Profile among Escherichia coli Urine Sample Isolates from Israeli Women with Acute Uncomplicated Cystitis Antimicrob. Agents Chemother., January 1, 2005; 49(1): 26 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Hidalgo-Tenorio, J Jimenez-Alonso, J de Dios Luna, M Tallada, A Martinez-Brocal, and J Mario Sabio Urinary tract infections and lupus erythematosus Ann Rheum Dis, April 1, 2004; 63(4): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Carlsson, M. Govoni, N. P. Wiklund, E. Weitzberg, and J. O. Lundberg In Vitro Evaluation of a New Treatment for Urinary Tract Infections Caused by Nitrate-Reducing Bacteria Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3713 - 3718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter, P. Menday, and O. Cars Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection J. Antimicrob. Chemother., December 1, 2003; 52(6): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Komp Lindgren, A. Karlsson, and D. Hughes Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3222 - 3232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Nilsson, O. G. Berg, O. Aspevall, G. Kahlmeter, and D. I. Andersson Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2850 - 2858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter and P. Menday Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO{middle dot}SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections J. Antimicrob. Chemother., July 1, 2003; 52(1): 128 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Efstathiou, A. V. Pefanis, D. I. Tsioulos, I. D. Zacharos, A. G. Tsiakou, A. G. Mitromaras, S. E. Mastorantonakis, S. N. Kanavaki, and T. D. Mountokalakis Acute Pyelonephritis in Adults: Prediction of Mortality and Failure of Treatment Arch Intern Med, May 26, 2003; 163(10): 1206 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kahlmeter An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO{middle dot}SENS Project J. Antimicrob. Chemother., January 1, 2003; 51(1): 69 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Kerrn, T. Klemmensen, N. Frimodt-Moller, and F. Espersen Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance J. Antimicrob. Chemother., October 1, 2002; 50(4): 513 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Hillier, J. T. Magee, A. J. Howard, and S. R. Palmer How strong is the evidence that antibiotic use is a risk factor for antibiotic-resistant, community-acquired urinary tract infection? J. Antimicrob. Chemother., August 1, 2002; 50(2): 241 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ishihara, S. Yokoi, N. Masue, T. Yamada, Y. Minamidate, M. Yasuda, M. Nakano, and T. Deguchi Urinary tract-derived Escherichia coli resistant to co-trimoxazole in Japan, where the drug is seldom used for treating acute urinary tract infections J. Antimicrob. Chemother., May 1, 2002; 49(5): 881 - 882. [Full Text] [PDF]
|
|
|
|
|
|
B. I. F. Batchelor, D. W. M. Crook, T. Jones, and I. C. J. W. Bowler Impact of guidelines for the diagnosis of urinary tract infection on trimethoprim susceptibility of Escherichia coli J. Antimicrob. Chemother., January 1, 2002; 49(1): 223 - 224. [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Manges, J. R. Johnson, B. Foxman, T. T. O'Bryan, K. E. Fullerton, and L. W. Riley Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-Resistant Escherichia coli Clonal Group N. Engl. J. Med., October 4, 2001; 345(14): 1007 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Roychoudhury, T. L. Twinem, K. M. Makin, E. J. McIntosh, B. Ledoussal, and C. E. Catrenich Activity of non-fluorinated quinolones (NFQs) against quinolone-resistant Escherichia coli and Streptococcus pneumoniae J. Antimicrob. Chemother., July 1, 2001; 48(1): 29 - 36. [Abstract] [Full Text] [PDF]
|
|